Patient Fact Sheets
This patient information fact sheet provides information on the definition, causes, symptoms, diagnostic tests, and treatments for multiple sclerosis.
The FDA has approved Simponi (golimumab for subcutaneous injection; Janssen Biotech) to induce and maintain clinical response in adults with ulcerative colitis.
Components of allergy can exist alone or in combination with others, including allergic rhinitis, allergic conjunctivitis, allergic sinusitis, allergic dermatitis, and allergic-induced asthma.
Asthma affects approximately 4.4 million U.S. children, and accounts for 2.9 million annual pediatric visits. A disproportionate number of children and adolescents with asthma are affected by depression and anxiety, compared to non-asthmatic controls. Asthma in youth is also linked with increased risk of suicide.
Learn more about mental health aspects of asthma in youth and find out how you can make a better diagnosis.
For women threatened with preterm labor, maintenance tocolysis with nifedipine is not associated with a significant reduction in adverse perinatal outcomes.
Patients with asthma are at higher risk of pulmonary embolism, particularly if the asthma is severe or they take oral corticosteroids.
Approaches for management of gout are presented in a two-part guideline.
Drugs in the Pipeline
Santarus announced results from its CORE I clinical study, one of two of the company's pivotal Phase 3 clinical studies with Uceris (budesonide) in ulcerative colitis.
Acton Pharmaceuticals announced that the FDA has approved the sNDA (Supplemental New Drug Application) for Aerospan (flunisolide HFA, 80mcg) inhalation aerosol, indicated for the maintenance treatment of asthma as a prophylactic therapy in adult and pediatric patients >6 years old.
Metastatic calcification of the left
breast in a patient with renal failure